跳转至内容
Merck
CN
  • Brain-Sparing Sympathofacilitators Mitigate Obesity without Adverse Cardiovascular Effects.

Brain-Sparing Sympathofacilitators Mitigate Obesity without Adverse Cardiovascular Effects.

Cell metabolism (2020-05-14)
Inês Mahú, Andreia Barateiro, Eva Rial-Pensado, Noelia Martinéz-Sánchez, Sandra H Vaz, Pedro M S D Cal, Benjamin Jenkins, Tiago Rodrigues, Carlos Cordeiro, Miguel F Costa, Raquel Mendes, Elsa Seixas, Mafalda M A Pereira, Nadiya Kubasova, Vitka Gres, Imogen Morris, Carolina Temporão, Marta Olivares, Yolanda Sanz, Albert Koulman, Francisco Corzana, Ana M Sebastião, Miguel López, Gonçalo J L Bernardes, Ana I Domingos
摘要

Anti-obesity drugs in the amphetamine (AMPH) class act in the brain to reduce appetite and increase locomotion. They are also characterized by adverse cardiovascular effects with origin that, despite absence of any in vivo evidence, is attributed to a direct sympathomimetic action in the heart. Here, we show that the cardiac side effects of AMPH originate from the brain and can be circumvented by PEGylation (PEGyAMPH) to exclude its central action. PEGyAMPH does not enter the brain and facilitates SNS activity via theβ2-adrenoceptor, protecting mice against obesity by increasing lipolysis and thermogenesis, coupled to higher heat dissipation, which acts as an energy sink to increase energy expenditure without altering food intake or locomotor activity. Thus, we provide proof-of-principle for a novel class of exclusively peripheral anti-obesity sympathofacilitators that are devoid of any cardiovascular and brain-related side effects.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
D -(+)-葡萄糖, ≥99.5% (GC)
Sigma-Aldrich
抗酪氨酸羟化酶抗体, Chemicon®, from rabbit
Sigma-Aldrich
游离甘油试剂, used for quantitative enzymatic determination of glycerol
Sigma-Aldrich
胶原酶 来源于溶组织梭菌, lyophilized powder, ≥125 CDU/mg solid (CDU = collagen digestion units), 0.5-5.0 FALGPA units/mg solid
Sigma-Aldrich
氯化乙酰胆碱, ≥99% (TLC)
Sigma-Aldrich
甘油标准品溶液, 2.5 mg/ml equivalent triolein concentration
Supelco
布托沙明 盐酸盐, analytical standard, for drug analysis, mixture of diastereomers
Sigma-Aldrich
Ribonuclease Inhibitor, Human, Recombinant, E. coli, The Ribonuclease Inhibitor, Human, Recombinant, E. coli controls the biological activity of Ribonuclease. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.